• On 27 June 2026, Addus HomeCare Corporation was removed from several major Russell Growth indices, including the Russell 3000 Growth, Russell 2000 Growth, and related small-cap growth benchmarks, following the latest index reconstitution.
• This simultaneous exit from multiple Russell growth benchmarks highlights how index membership can influence trading activity around a mid-cap healthcare services company like Addus.
• We’ll now examine how Addus’s removal from multiple Russell Growth indices could affect its existing investment narrative and risk profile.

The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Addus HomeCare Investment Narrative Recap

To own Addus HomeCare, you need to believe that demand for home and community based care, backed by Medicaid and Medicare funding, can support steady earnings despite reimbursement and labor pressures. The recent removal from multiple Russell Growth indices mainly matters for near term trading liquidity rather than fundamentals, and does not materially change the key short term catalyst of reimbursement-driven revenue growth or the principal risk around government payment cuts and policy shifts.

In that context, the recent Q1 2026 results, with net income of US$25.07 million and diluted EPS of US$1.36, are an important data point. They reinforce that the company is currently executing on margin and earnings quality while it continues to invest for growth through acquisitions and technology, even as investors reassess the stock after the Russell index removals and weigh those results against reimbursement and workforce risks.

Yet, despite this solid recent profitability, investors should also be aware that...

Addus HomeCare's narrative projects $1.7 billion revenue and $136.9 million earnings by 2028. This requires 10.1% yearly revenue growth and about a $53.9 million earnings increase from $83.0 million today.

Uncover how Addus HomeCare's forecasts yield a $142.91 fair value, a 47% upside to its current price.

Exploring Other Perspectives

Some of the lowest analysts were already cautious, assuming earnings of about US$124.8 million by 2029 and only 4.3 percent annual revenue growth, so you should recognize that views can differ widely and may shift again after Addus’s Russell index exit.

Explore 5 other fair value estimates on Addus HomeCare - why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Addus HomeCare research is our analysis highlighting 5 key rewards that could impact your investment decision.
• Our free Addus HomeCare research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Addus HomeCare's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
• Capitalize on the AI infrastructure supercycle with our selection of the 51 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.